Hospital Acquired Infections Diagnostics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET INTRODUCTION
Hospital Acquired Infections (HAI) Diagnostics are to diagnose different hospital acquired diseases during the stay in hospital. Hospital acquired disease are the local or systemic condition or infection which usually occur by adverse effect from medicine, medical care or by coming in contact with bacteria and other toxins. Hospital acquired infection having higher mortality rates. The infection can also be due to catheter blood stream infection, infection at surgical site, pneumonia from ventilator, urinary tract infections. These infections can be acquired in OPD, clinic setting, OT, Rehabilitation center etc.
MARKET DYNAMICS
The key market drivers for Hospital Acquired Infections (HAI) Diagnostics Market Includes, increase prevalence of hospital acquired disease, rising geriatric population across the globe, rising length of stay in hospital are some of the factors which are expected to drive market growth during the forecast period. However, improvement in medical care facilities, decreased prevalence of HAI in developed countries are expected to hinder market growth during forecast period.
MARKET SCOPE
The "Hospital Acquired Infections (HAI) Diagnostics Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Hospital Acquired Infections (HAI) Diagnostics market with detailed market segmentation by product, test type, application, infection type and end user. The Hospital Acquired Infections (HAI) Diagnostics Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Hospital Acquired Infections (HAI) Diagnostics Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Hospital Acquired Infections (HAI) Diagnostics Market is segmented on the basis of product, test type, application, infection type and end user. On the basis of product the market is segmented into, instruments and consumables. On the basis of test type the market is segmented into, molecular diagnostics, urinalysis, immunoassay. On the basis of application market is segmented into, disease testing, drug-resistance testing. On basis of infection type market is segmented as, hospital acquired pneumonia, bloodstream infections, surgical site infections and other infections. And on the basis of end users the market is segmented as, hospital, clinic and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Hospital Acquired Infections (HAI) Diagnostics Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Hospital Acquired Infections (HAI) Diagnostics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Hospital Acquired Infections (HAI) Diagnostics Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Hospital Acquired Infections (HAI) Diagnostics Market in these regions.
Speak to Analyst
MARKET PLAYERS
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Hospital Acquired Infections (HAI) Diagnostics Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Hospital Acquired Infections (HAI) Diagnostics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Hospital Acquired Infections (HAI) Diagnostics Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Hospital Acquired Infections (HAI) Diagnostics Market in these regions.
MARKET PLAYERS
The report covers key developments in the Hospital Acquired Infections (HAI) Diagnostics Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Hospital Acquired Infections (HAI) Diagnostics Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Hospital Acquired Infections (HAI) Diagnostics market in the global market. Below mentioned is the list of few companies engaged in the Hospital Acquired Infections (HAI) Diagnostics Market.
The report also includes the profiles of key players in Hospital Acquired Infections (HAI) Diagnostics Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Hospital Acquired Infections (HAI) Diagnostics are to diagnose different hospital acquired diseases during the stay in hospital. Hospital acquired disease are the local or systemic condition or infection which usually occur by adverse effect from medicine, medical care or by coming in contact with bacteria and other toxins. Hospital acquired infection having higher mortality rates. The infection can also be due to catheter blood stream infection, infection at surgical site, pneumonia from ventilator, urinary tract infections. These infections can be acquired in OPD, clinic setting, OT, Rehabilitation center etc.
MARKET DYNAMICS
The key market drivers for Hospital Acquired Infections (HAI) Diagnostics Market Includes, increase prevalence of hospital acquired disease, rising geriatric population across the globe, rising length of stay in hospital are some of the factors which are expected to drive market growth during the forecast period. However, improvement in medical care facilities, decreased prevalence of HAI in developed countries are expected to hinder market growth during forecast period.
MARKET SCOPE
The "Hospital Acquired Infections (HAI) Diagnostics Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Hospital Acquired Infections (HAI) Diagnostics market with detailed market segmentation by product, test type, application, infection type and end user. The Hospital Acquired Infections (HAI) Diagnostics Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Hospital Acquired Infections (HAI) Diagnostics Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Hospital Acquired Infections (HAI) Diagnostics Market is segmented on the basis of product, test type, application, infection type and end user. On the basis of product the market is segmented into, instruments and consumables. On the basis of test type the market is segmented into, molecular diagnostics, urinalysis, immunoassay. On the basis of application market is segmented into, disease testing, drug-resistance testing. On basis of infection type market is segmented as, hospital acquired pneumonia, bloodstream infections, surgical site infections and other infections. And on the basis of end users the market is segmented as, hospital, clinic and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Hospital Acquired Infections (HAI) Diagnostics Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Hospital Acquired Infections (HAI) Diagnostics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Hospital Acquired Infections (HAI) Diagnostics Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Hospital Acquired Infections (HAI) Diagnostics Market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Hospital Acquired Infections (HAI) Diagnostics Market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Hospital Acquired Infections (HAI) Diagnostics Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Hospital Acquired Infections (HAI) Diagnostics Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Hospital Acquired Infections (HAI) Diagnostics Market in these regions.
MARKET PLAYERS
The report covers key developments in the Hospital Acquired Infections (HAI) Diagnostics Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Hospital Acquired Infections (HAI) Diagnostics Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Hospital Acquired Infections (HAI) Diagnostics market in the global market. Below mentioned is the list of few companies engaged in the Hospital Acquired Infections (HAI) Diagnostics Market.
The report also includes the profiles of key players in Hospital Acquired Infections (HAI) Diagnostics Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.
- Abbott Laboratories
- Alere,Inc
- BD
- AdvanDX
- Hologic,Inc
- AstraZeneca Plc
- Roche AG
- Bayer Schering Pharma LLC
- Cepheid Inc
- Daiichi Sankyo
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hospital Acquired Infections Diagnostics Market - By Product
1.3.2 Hospital Acquired Infections Diagnostics Market - By Test Type
1.3.3 Hospital Acquired Infections Diagnostics Market - By Application
1.3.4 Hospital Acquired Infections Diagnostics Market - By Infection Type
1.3.5 Hospital Acquired Infections Diagnostics Market - By End Users
1.3.6 Hospital Acquired Infections Diagnostics Market - By Region
1.3.6.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENT AND REAGENTS
7.3.1. Overview
7.3.2. Instrument and Reagents Market Forecast and Analysis
7.4. CONSUMABLES
7.4.1. Overview
7.4.2. Consumables Market Forecast and Analysis
8. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - TEST TYPE
8.1. OVERVIEW
8.2. TEST TYPE MARKET FORECASTS AND ANALYSIS
8.3. MOLECULAR DIAGNOSTICS
8.3.1. Overview
8.3.2. Molecular Diagnostics Market Forecast and Analysis
8.4. URINALYSIS
8.4.1. Overview
8.4.2. Urinalysis Market Forecast and Analysis
8.5. IMMUNOASSAY
8.5.1. Overview
8.5.2. Immunoassay Market Forecast and Analysis
9. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. DISEASE TESTING
9.3.1. Overview
9.3.2. Disease Testing Market Forecast and Analysis
9.4. DRUG-RESISTANCE TESTING
9.4.1. Overview
9.4.2. Drug-Resistance Testing Market Forecast and Analysis
10. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - INFECTION TYPE
10.1. OVERVIEW
10.2. INFECTION TYPE MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL ACQUIRED PNEUMONIA
10.3.1. Overview
10.3.2. Hospital Acquired Pneumonia Market Forecast and Analysis
10.4. BLOODSTREAM INFECTIONS
10.4.1. Overview
10.4.2. Bloodstream Infections Market Forecast and Analysis
10.5. SURGICAL SITE INFECTIONS
10.5.1. Overview
10.5.2. Surgical Site Infections Market Forecast and Analysis
10.6. GASTROINTESTINAL INFECTIONS
10.6.1. Overview
10.6.2. Gastrointestinal Infections Market Forecast and Analysis
10.7. OTHERS
10.7.1. Overview
10.7.2. Others Market Forecast and Analysis
11. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - END USERS
11.1. OVERVIEW
11.2. END USERS MARKET FORECASTS AND ANALYSIS
11.3. HOSPITAL
11.3.1. Overview
11.3.2. Hospital Market Forecast and Analysis
11.4. CLINICS
11.4.1. Overview
11.4.2. Clinics Market Forecast and Analysis
11.5. OTHERS
11.5.1. Overview
11.5.2. others Market Forecast and Analysis
12. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Hospital Acquired Infections Diagnostics Market Overview
12.1.2 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis
12.1.3 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Product
12.1.4 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Test Type
12.1.5 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Application
12.1.6 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Infection Type
12.1.7 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By End Users
12.1.8 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Countries
12.1.8.1 United States Hospital Acquired Infections Diagnostics Market
12.1.8.1.1 United States Hospital Acquired Infections Diagnostics Market by Product
12.1.8.1.2 United States Hospital Acquired Infections Diagnostics Market by Test Type
12.1.8.1.3 United States Hospital Acquired Infections Diagnostics Market by Application
12.1.8.1.4 United States Hospital Acquired Infections Diagnostics Market by Infection Type
12.1.8.1.5 United States Hospital Acquired Infections Diagnostics Market by End Users
12.1.8.2 Canada Hospital Acquired Infections Diagnostics Market
12.1.8.2.1 Canada Hospital Acquired Infections Diagnostics Market by Product
12.1.8.2.2 Canada Hospital Acquired Infections Diagnostics Market by Test Type
12.1.8.2.3 Canada Hospital Acquired Infections Diagnostics Market by Application
12.1.8.2.4 Canada Hospital Acquired Infections Diagnostics Market by Infection Type
12.1.8.2.5 Canada Hospital Acquired Infections Diagnostics Market by End Users
12.1.8.3 Mexico Hospital Acquired Infections Diagnostics Market
12.1.8.3.1 Mexico Hospital Acquired Infections Diagnostics Market by Product
12.1.8.3.2 Mexico Hospital Acquired Infections Diagnostics Market by Test Type
12.1.8.3.3 Mexico Hospital Acquired Infections Diagnostics Market by Application
12.1.8.3.4 Mexico Hospital Acquired Infections Diagnostics Market by Infection Type
12.1.8.3.5 Mexico Hospital Acquired Infections Diagnostics Market by End Users
12.2. EUROPE
12.2.1 Europe Hospital Acquired Infections Diagnostics Market Overview
12.2.2 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis
12.2.3 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Product
12.2.4 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Test Type
12.2.5 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Application
12.2.6 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Infection Type
12.2.7 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By End Users
12.2.8 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Hospital Acquired Infections Diagnostics Market
12.2.8.1.1 Germany Hospital Acquired Infections Diagnostics Market by Product
12.2.8.1.2 Germany Hospital Acquired Infections Diagnostics Market by Test Type
12.2.8.1.3 Germany Hospital Acquired Infections Diagnostics Market by Application
12.2.8.1.4 Germany Hospital Acquired Infections Diagnostics Market by Infection Type
12.2.8.1.5 Germany Hospital Acquired Infections Diagnostics Market by End Users
12.2.8.2 France Hospital Acquired Infections Diagnostics Market
12.2.8.2.1 France Hospital Acquired Infections Diagnostics Market by Product
12.2.8.2.2 France Hospital Acquired Infections Diagnostics Market by Test Type
12.2.8.2.3 France Hospital Acquired Infections Diagnostics Market by Application
12.2.8.2.4 France Hospital Acquired Infections Diagnostics Market by Infection Type
12.2.8.2.5 France Hospital Acquired Infections Diagnostics Market by End Users
12.2.8.3 Italy Hospital Acquired Infections Diagnostics Market
12.2.8.3.1 Italy Hospital Acquired Infections Diagnostics Market by Product
12.2.8.3.2 Italy Hospital Acquired Infections Diagnostics Market by Test Type
12.2.8.3.3 Italy Hospital Acquired Infections Diagnostics Market by Application
12.2.8.3.4 Italy Hospital Acquired Infections Diagnostics Market by Infection Type
12.2.8.3.5 Italy Hospital Acquired Infections Diagnostics Market by End Users
12.2.8.4 Spain Hospital Acquired Infections Diagnostics Market
12.2.8.4.1 Spain Hospital Acquired Infections Diagnostics Market by Product
12.2.8.4.2 Spain Hospital Acquired Infections Diagnostics Market by Test Type
12.2.8.4.3 Spain Hospital Acquired Infections Diagnostics Market by Application
12.2.8.4.4 Spain Hospital Acquired Infections Diagnostics Market by Infection Type
12.2.8.4.5 Spain Hospital Acquired Infections Diagnostics Market by End Users
12.2.8.5 United Kingdom Hospital Acquired Infections Diagnostics Market
12.2.8.5.1 United Kingdom Hospital Acquired Infections Diagnostics Market by Product
12.2.8.5.2 United Kingdom Hospital Acquired Infections Diagnostics Market by Test Type
12.2.8.5.3 United Kingdom Hospital Acquired Infections Diagnostics Market by Application
12.2.8.5.4 United Kingdom Hospital Acquired Infections Diagnostics Market by Infection Type
12.2.8.5.5 United Kingdom Hospital Acquired Infections Diagnostics Market by End Users
12.2.8.6 Rest of Europe Hospital Acquired Infections Diagnostics Market
12.2.8.6.1 Rest of Europe Hospital Acquired Infections Diagnostics Market by Product
12.2.8.6.2 Rest of Europe Hospital Acquired Infections Diagnostics Market by Test Type
12.2.8.6.3 Rest of Europe Hospital Acquired Infections Diagnostics Market by Application
12.2.8.6.4 Rest of Europe Hospital Acquired Infections Diagnostics Market by Infection Type
12.2.8.6.5 Rest of Europe Hospital Acquired Infections Diagnostics Market by End Users
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Hospital Acquired Infections Diagnostics Market Overview
12.3.2 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis
12.3.3 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Product
12.3.4 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Test Type
12.3.5 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Application
12.3.6 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Infection Type
12.3.7 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By End Users
12.3.8 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Hospital Acquired Infections Diagnostics Market
12.3.8.1.1 Australia Hospital Acquired Infections Diagnostics Market by Product
12.3.8.1.2 Australia Hospital Acquired Infections Diagnostics Market by Test Type
12.3.8.1.3 Australia Hospital Acquired Infections Diagnostics Market by Application
12.3.8.1.4 Australia Hospital Acquired Infections Diagnostics Market by Infection Type
12.3.8.1.5 Australia Hospital Acquired Infections Diagnostics Market by End Users
12.3.8.2 China Hospital Acquired Infections Diagnostics Market
12.3.8.2.1 China Hospital Acquired Infections Diagnostics Market by Product
12.3.8.2.2 China Hospital Acquired Infections Diagnostics Market by Test Type
12.3.8.2.3 China Hospital Acquired Infections Diagnostics Market by Application
12.3.8.2.4 China Hospital Acquired Infections Diagnostics Market by Infection Type
12.3.8.2.5 China Hospital Acquired Infections Diagnostics Market by End Users
12.3.8.3 India Hospital Acquired Infections Diagnostics Market
12.3.8.3.1 India Hospital Acquired Infections Diagnostics Market by Product
12.3.8.3.2 India Hospital Acquired Infections Diagnostics Market by Test Type
12.3.8.3.3 India Hospital Acquired Infections Diagnostics Market by Application
12.3.8.3.4 India Hospital Acquired Infections Diagnostics Market by Infection Type
12.3.8.3.5 India Hospital Acquired Infections Diagnostics Market by End Users
12.3.8.4 Japan Hospital Acquired Infections Diagnostics Market
12.3.8.4.1 Japan Hospital Acquired Infections Diagnostics Market by Product
12.3.8.4.2 Japan Hospital Acquired Infections Diagnostics Market by Test Type
12.3.8.4.3 Japan Hospital Acquired Infections Diagnostics Market by Application
12.3.8.4.4 Japan Hospital Acquired Infections Diagnostics Market by Infection Type
12.3.8.4.5 Japan Hospital Acquired Infections Diagnostics Market by End Users
12.3.8.5 South Korea Hospital Acquired Infections Diagnostics Market
12.3.8.5.1 South Korea Hospital Acquired Infections Diagnostics Market by Product
12.3.8.5.2 South Korea Hospital Acquired Infections Diagnostics Market by Test Type
12.3.8.5.3 South Korea Hospital Acquired Infections Diagnostics Market by Application
12.3.8.5.4 South Korea Hospital Acquired Infections Diagnostics Market by Infection Type
12.3.8.5.5 South Korea Hospital Acquired Infections Diagnostics Market by End Users
12.3.8.6 Rest of Asia-Pacific Hospital Acquired Infections Diagnostics Market
12.3.8.6.1 Rest of Asia-Pacific Hospital Acquired Infections Diagnostics Market by Product
12.3.8.6.2 Rest of Asia-Pacific Hospital Acquired Infections Diagnostics Market by Test Type
12.3.8.6.3 Rest of Asia-Pacific Hospital Acquired Infections Diagnostics Market by Application
12.3.8.6.4 Rest of Asia-Pacific Hospital Acquired Infections Diagnostics Market by Infection Type
12.3.8.6.5 Rest of Asia-Pacific Hospital Acquired Infections Diagnostics Market by End Users
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Hospital Acquired Infections Diagnostics Market Overview
12.4.2 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis
12.4.3 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Product
12.4.4 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Test Type
12.4.5 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Application
12.4.6 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Infection Type
12.4.7 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By End Users
12.4.8 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Hospital Acquired Infections Diagnostics Market
12.4.8.1.1 South Africa Hospital Acquired Infections Diagnostics Market by Product
12.4.8.1.2 South Africa Hospital Acquired Infections Diagnostics Market by Test Type
12.4.8.1.3 South Africa Hospital Acquired Infections Diagnostics Market by Application
12.4.8.1.4 South Africa Hospital Acquired Infections Diagnostics Market by Infection Type
12.4.8.1.5 South Africa Hospital Acquired Infections Diagnostics Market by End Users
12.4.8.2 Saudi Arabia Hospital Acquired Infections Diagnostics Market
12.4.8.2.1 Saudi Arabia Hospital Acquired Infections Diagnostics Market by Product
12.4.8.2.2 Saudi Arabia Hospital Acquired Infections Diagnostics Market by Test Type
12.4.8.2.3 Saudi Arabia Hospital Acquired Infections Diagnostics Market by Application
12.4.8.2.4 Saudi Arabia Hospital Acquired Infections Diagnostics Market by Infection Type
12.4.8.2.5 Saudi Arabia Hospital Acquired Infections Diagnostics Market by End Users
12.4.8.3 U.A.E Hospital Acquired Infections Diagnostics Market
12.4.8.3.1 U.A.E Hospital Acquired Infections Diagnostics Market by Product
12.4.8.3.2 U.A.E Hospital Acquired Infections Diagnostics Market by Test Type
12.4.8.3.3 U.A.E Hospital Acquired Infections Diagnostics Market by Application
12.4.8.3.4 U.A.E Hospital Acquired Infections Diagnostics Market by Infection Type
12.4.8.3.5 U.A.E Hospital Acquired Infections Diagnostics Market by End Users
12.4.8.4 Rest of Middle East and Africa Hospital Acquired Infections Diagnostics Market
12.4.8.4.1 Rest of Middle East and Africa Hospital Acquired Infections Diagnostics Market by Product
12.4.8.4.2 Rest of Middle East and Africa Hospital Acquired Infections Diagnostics Market by Test Type
12.4.8.4.3 Rest of Middle East and Africa Hospital Acquired Infections Diagnostics Market by Application
12.4.8.4.4 Rest of Middle East and Africa Hospital Acquired Infections Diagnostics Market by Infection Type
12.4.8.4.5 Rest of Middle East and Africa Hospital Acquired Infections Diagnostics Market by End Users
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Hospital Acquired Infections Diagnostics Market Overview
12.5.2 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis
12.5.3 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Product
12.5.4 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Test Type
12.5.5 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Application
12.5.6 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Infection Type
12.5.7 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By End Users
12.5.8 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Hospital Acquired Infections Diagnostics Market
12.5.8.1.1 Brazil Hospital Acquired Infections Diagnostics Market by Product
12.5.8.1.2 Brazil Hospital Acquired Infections Diagnostics Market by Test Type
12.5.8.1.3 Brazil Hospital Acquired Infections Diagnostics Market by Application
12.5.8.1.4 Brazil Hospital Acquired Infections Diagnostics Market by Infection Type
12.5.8.1.5 Brazil Hospital Acquired Infections Diagnostics Market by End Users
12.5.8.2 Argentina Hospital Acquired Infections Diagnostics Market
12.5.8.2.1 Argentina Hospital Acquired Infections Diagnostics Market by Product
12.5.8.2.2 Argentina Hospital Acquired Infections Diagnostics Market by Test Type
12.5.8.2.3 Argentina Hospital Acquired Infections Diagnostics Market by Application
12.5.8.2.4 Argentina Hospital Acquired Infections Diagnostics Market by Infection Type
12.5.8.2.5 Argentina Hospital Acquired Infections Diagnostics Market by End Users
12.5.8.3 Rest of South and Central America Hospital Acquired Infections Diagnostics Market
12.5.8.3.1 Rest of South and Central America Hospital Acquired Infections Diagnostics Market by Product
12.5.8.3.2 Rest of South and Central America Hospital Acquired Infections Diagnostics Market by Test Type
12.5.8.3.3 Rest of South and Central America Hospital Acquired Infections Diagnostics Market by Application
12.5.8.3.4 Rest of South and Central America Hospital Acquired Infections Diagnostics Market by Infection Type
12.5.8.3.5 Rest of South and Central America Hospital Acquired Infections Diagnostics Market by End Users
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET, KEY COMPANY PROFILES
14.1. ABBOTT LABORATORIES
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. ADVANDX
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. ALERE INC.
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. ASTRAZENECA PLC
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. BECTON DICKINSON AND COMPANY
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. HOLOGIC, INC
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. BAYER SCHERING PHARMA LLC
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. CEPHEID INC
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. ROCHE AG
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. DAIICHI SANKYO
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hospital Acquired Infections Diagnostics Market - By Product
1.3.2 Hospital Acquired Infections Diagnostics Market - By Test Type
1.3.3 Hospital Acquired Infections Diagnostics Market - By Application
1.3.4 Hospital Acquired Infections Diagnostics Market - By Infection Type
1.3.5 Hospital Acquired Infections Diagnostics Market - By End Users
1.3.6 Hospital Acquired Infections Diagnostics Market - By Region
1.3.6.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS - GLOBAL MARKET OVERVIEW
6.2. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENT AND REAGENTS
7.3.1. Overview
7.3.2. Instrument and Reagents Market Forecast and Analysis
7.4. CONSUMABLES
7.4.1. Overview
7.4.2. Consumables Market Forecast and Analysis
8. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - TEST TYPE
8.1. OVERVIEW
8.2. TEST TYPE MARKET FORECASTS AND ANALYSIS
8.3. MOLECULAR DIAGNOSTICS
8.3.1. Overview
8.3.2. Molecular Diagnostics Market Forecast and Analysis
8.4. URINALYSIS
8.4.1. Overview
8.4.2. Urinalysis Market Forecast and Analysis
8.5. IMMUNOASSAY
8.5.1. Overview
8.5.2. Immunoassay Market Forecast and Analysis
9. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. DISEASE TESTING
9.3.1. Overview
9.3.2. Disease Testing Market Forecast and Analysis
9.4. DRUG-RESISTANCE TESTING
9.4.1. Overview
9.4.2. Drug-Resistance Testing Market Forecast and Analysis
10. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - INFECTION TYPE
10.1. OVERVIEW
10.2. INFECTION TYPE MARKET FORECASTS AND ANALYSIS
10.3. HOSPITAL ACQUIRED PNEUMONIA
10.3.1. Overview
10.3.2. Hospital Acquired Pneumonia Market Forecast and Analysis
10.4. BLOODSTREAM INFECTIONS
10.4.1. Overview
10.4.2. Bloodstream Infections Market Forecast and Analysis
10.5. SURGICAL SITE INFECTIONS
10.5.1. Overview
10.5.2. Surgical Site Infections Market Forecast and Analysis
10.6. GASTROINTESTINAL INFECTIONS
10.6.1. Overview
10.6.2. Gastrointestinal Infections Market Forecast and Analysis
10.7. OTHERS
10.7.1. Overview
10.7.2. Others Market Forecast and Analysis
11. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - END USERS
11.1. OVERVIEW
11.2. END USERS MARKET FORECASTS AND ANALYSIS
11.3. HOSPITAL
11.3.1. Overview
11.3.2. Hospital Market Forecast and Analysis
11.4. CLINICS
11.4.1. Overview
11.4.2. Clinics Market Forecast and Analysis
11.5. OTHERS
11.5.1. Overview
11.5.2. others Market Forecast and Analysis
12. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Hospital Acquired Infections Diagnostics Market Overview
12.1.2 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis
12.1.3 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Product
12.1.4 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Test Type
12.1.5 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Application
12.1.6 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Infection Type
12.1.7 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By End Users
12.1.8 North America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Countries
12.1.8.1 United States Hospital Acquired Infections Diagnostics Market
12.1.8.1.1 United States Hospital Acquired Infections Diagnostics Market by Product
12.1.8.1.2 United States Hospital Acquired Infections Diagnostics Market by Test Type
12.1.8.1.3 United States Hospital Acquired Infections Diagnostics Market by Application
12.1.8.1.4 United States Hospital Acquired Infections Diagnostics Market by Infection Type
12.1.8.1.5 United States Hospital Acquired Infections Diagnostics Market by End Users
12.1.8.2 Canada Hospital Acquired Infections Diagnostics Market
12.1.8.2.1 Canada Hospital Acquired Infections Diagnostics Market by Product
12.1.8.2.2 Canada Hospital Acquired Infections Diagnostics Market by Test Type
12.1.8.2.3 Canada Hospital Acquired Infections Diagnostics Market by Application
12.1.8.2.4 Canada Hospital Acquired Infections Diagnostics Market by Infection Type
12.1.8.2.5 Canada Hospital Acquired Infections Diagnostics Market by End Users
12.1.8.3 Mexico Hospital Acquired Infections Diagnostics Market
12.1.8.3.1 Mexico Hospital Acquired Infections Diagnostics Market by Product
12.1.8.3.2 Mexico Hospital Acquired Infections Diagnostics Market by Test Type
12.1.8.3.3 Mexico Hospital Acquired Infections Diagnostics Market by Application
12.1.8.3.4 Mexico Hospital Acquired Infections Diagnostics Market by Infection Type
12.1.8.3.5 Mexico Hospital Acquired Infections Diagnostics Market by End Users
12.2. EUROPE
12.2.1 Europe Hospital Acquired Infections Diagnostics Market Overview
12.2.2 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis
12.2.3 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Product
12.2.4 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Test Type
12.2.5 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Application
12.2.6 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Infection Type
12.2.7 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By End Users
12.2.8 Europe Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Hospital Acquired Infections Diagnostics Market
12.2.8.1.1 Germany Hospital Acquired Infections Diagnostics Market by Product
12.2.8.1.2 Germany Hospital Acquired Infections Diagnostics Market by Test Type
12.2.8.1.3 Germany Hospital Acquired Infections Diagnostics Market by Application
12.2.8.1.4 Germany Hospital Acquired Infections Diagnostics Market by Infection Type
12.2.8.1.5 Germany Hospital Acquired Infections Diagnostics Market by End Users
12.2.8.2 France Hospital Acquired Infections Diagnostics Market
12.2.8.2.1 France Hospital Acquired Infections Diagnostics Market by Product
12.2.8.2.2 France Hospital Acquired Infections Diagnostics Market by Test Type
12.2.8.2.3 France Hospital Acquired Infections Diagnostics Market by Application
12.2.8.2.4 France Hospital Acquired Infections Diagnostics Market by Infection Type
12.2.8.2.5 France Hospital Acquired Infections Diagnostics Market by End Users
12.2.8.3 Italy Hospital Acquired Infections Diagnostics Market
12.2.8.3.1 Italy Hospital Acquired Infections Diagnostics Market by Product
12.2.8.3.2 Italy Hospital Acquired Infections Diagnostics Market by Test Type
12.2.8.3.3 Italy Hospital Acquired Infections Diagnostics Market by Application
12.2.8.3.4 Italy Hospital Acquired Infections Diagnostics Market by Infection Type
12.2.8.3.5 Italy Hospital Acquired Infections Diagnostics Market by End Users
12.2.8.4 Spain Hospital Acquired Infections Diagnostics Market
12.2.8.4.1 Spain Hospital Acquired Infections Diagnostics Market by Product
12.2.8.4.2 Spain Hospital Acquired Infections Diagnostics Market by Test Type
12.2.8.4.3 Spain Hospital Acquired Infections Diagnostics Market by Application
12.2.8.4.4 Spain Hospital Acquired Infections Diagnostics Market by Infection Type
12.2.8.4.5 Spain Hospital Acquired Infections Diagnostics Market by End Users
12.2.8.5 United Kingdom Hospital Acquired Infections Diagnostics Market
12.2.8.5.1 United Kingdom Hospital Acquired Infections Diagnostics Market by Product
12.2.8.5.2 United Kingdom Hospital Acquired Infections Diagnostics Market by Test Type
12.2.8.5.3 United Kingdom Hospital Acquired Infections Diagnostics Market by Application
12.2.8.5.4 United Kingdom Hospital Acquired Infections Diagnostics Market by Infection Type
12.2.8.5.5 United Kingdom Hospital Acquired Infections Diagnostics Market by End Users
12.2.8.6 Rest of Europe Hospital Acquired Infections Diagnostics Market
12.2.8.6.1 Rest of Europe Hospital Acquired Infections Diagnostics Market by Product
12.2.8.6.2 Rest of Europe Hospital Acquired Infections Diagnostics Market by Test Type
12.2.8.6.3 Rest of Europe Hospital Acquired Infections Diagnostics Market by Application
12.2.8.6.4 Rest of Europe Hospital Acquired Infections Diagnostics Market by Infection Type
12.2.8.6.5 Rest of Europe Hospital Acquired Infections Diagnostics Market by End Users
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Hospital Acquired Infections Diagnostics Market Overview
12.3.2 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis
12.3.3 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Product
12.3.4 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Test Type
12.3.5 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Application
12.3.6 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Infection Type
12.3.7 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By End Users
12.3.8 Asia-Pacific Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Hospital Acquired Infections Diagnostics Market
12.3.8.1.1 Australia Hospital Acquired Infections Diagnostics Market by Product
12.3.8.1.2 Australia Hospital Acquired Infections Diagnostics Market by Test Type
12.3.8.1.3 Australia Hospital Acquired Infections Diagnostics Market by Application
12.3.8.1.4 Australia Hospital Acquired Infections Diagnostics Market by Infection Type
12.3.8.1.5 Australia Hospital Acquired Infections Diagnostics Market by End Users
12.3.8.2 China Hospital Acquired Infections Diagnostics Market
12.3.8.2.1 China Hospital Acquired Infections Diagnostics Market by Product
12.3.8.2.2 China Hospital Acquired Infections Diagnostics Market by Test Type
12.3.8.2.3 China Hospital Acquired Infections Diagnostics Market by Application
12.3.8.2.4 China Hospital Acquired Infections Diagnostics Market by Infection Type
12.3.8.2.5 China Hospital Acquired Infections Diagnostics Market by End Users
12.3.8.3 India Hospital Acquired Infections Diagnostics Market
12.3.8.3.1 India Hospital Acquired Infections Diagnostics Market by Product
12.3.8.3.2 India Hospital Acquired Infections Diagnostics Market by Test Type
12.3.8.3.3 India Hospital Acquired Infections Diagnostics Market by Application
12.3.8.3.4 India Hospital Acquired Infections Diagnostics Market by Infection Type
12.3.8.3.5 India Hospital Acquired Infections Diagnostics Market by End Users
12.3.8.4 Japan Hospital Acquired Infections Diagnostics Market
12.3.8.4.1 Japan Hospital Acquired Infections Diagnostics Market by Product
12.3.8.4.2 Japan Hospital Acquired Infections Diagnostics Market by Test Type
12.3.8.4.3 Japan Hospital Acquired Infections Diagnostics Market by Application
12.3.8.4.4 Japan Hospital Acquired Infections Diagnostics Market by Infection Type
12.3.8.4.5 Japan Hospital Acquired Infections Diagnostics Market by End Users
12.3.8.5 South Korea Hospital Acquired Infections Diagnostics Market
12.3.8.5.1 South Korea Hospital Acquired Infections Diagnostics Market by Product
12.3.8.5.2 South Korea Hospital Acquired Infections Diagnostics Market by Test Type
12.3.8.5.3 South Korea Hospital Acquired Infections Diagnostics Market by Application
12.3.8.5.4 South Korea Hospital Acquired Infections Diagnostics Market by Infection Type
12.3.8.5.5 South Korea Hospital Acquired Infections Diagnostics Market by End Users
12.3.8.6 Rest of Asia-Pacific Hospital Acquired Infections Diagnostics Market
12.3.8.6.1 Rest of Asia-Pacific Hospital Acquired Infections Diagnostics Market by Product
12.3.8.6.2 Rest of Asia-Pacific Hospital Acquired Infections Diagnostics Market by Test Type
12.3.8.6.3 Rest of Asia-Pacific Hospital Acquired Infections Diagnostics Market by Application
12.3.8.6.4 Rest of Asia-Pacific Hospital Acquired Infections Diagnostics Market by Infection Type
12.3.8.6.5 Rest of Asia-Pacific Hospital Acquired Infections Diagnostics Market by End Users
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Hospital Acquired Infections Diagnostics Market Overview
12.4.2 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis
12.4.3 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Product
12.4.4 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Test Type
12.4.5 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Application
12.4.6 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Infection Type
12.4.7 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By End Users
12.4.8 Middle East and Africa Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Hospital Acquired Infections Diagnostics Market
12.4.8.1.1 South Africa Hospital Acquired Infections Diagnostics Market by Product
12.4.8.1.2 South Africa Hospital Acquired Infections Diagnostics Market by Test Type
12.4.8.1.3 South Africa Hospital Acquired Infections Diagnostics Market by Application
12.4.8.1.4 South Africa Hospital Acquired Infections Diagnostics Market by Infection Type
12.4.8.1.5 South Africa Hospital Acquired Infections Diagnostics Market by End Users
12.4.8.2 Saudi Arabia Hospital Acquired Infections Diagnostics Market
12.4.8.2.1 Saudi Arabia Hospital Acquired Infections Diagnostics Market by Product
12.4.8.2.2 Saudi Arabia Hospital Acquired Infections Diagnostics Market by Test Type
12.4.8.2.3 Saudi Arabia Hospital Acquired Infections Diagnostics Market by Application
12.4.8.2.4 Saudi Arabia Hospital Acquired Infections Diagnostics Market by Infection Type
12.4.8.2.5 Saudi Arabia Hospital Acquired Infections Diagnostics Market by End Users
12.4.8.3 U.A.E Hospital Acquired Infections Diagnostics Market
12.4.8.3.1 U.A.E Hospital Acquired Infections Diagnostics Market by Product
12.4.8.3.2 U.A.E Hospital Acquired Infections Diagnostics Market by Test Type
12.4.8.3.3 U.A.E Hospital Acquired Infections Diagnostics Market by Application
12.4.8.3.4 U.A.E Hospital Acquired Infections Diagnostics Market by Infection Type
12.4.8.3.5 U.A.E Hospital Acquired Infections Diagnostics Market by End Users
12.4.8.4 Rest of Middle East and Africa Hospital Acquired Infections Diagnostics Market
12.4.8.4.1 Rest of Middle East and Africa Hospital Acquired Infections Diagnostics Market by Product
12.4.8.4.2 Rest of Middle East and Africa Hospital Acquired Infections Diagnostics Market by Test Type
12.4.8.4.3 Rest of Middle East and Africa Hospital Acquired Infections Diagnostics Market by Application
12.4.8.4.4 Rest of Middle East and Africa Hospital Acquired Infections Diagnostics Market by Infection Type
12.4.8.4.5 Rest of Middle East and Africa Hospital Acquired Infections Diagnostics Market by End Users
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Hospital Acquired Infections Diagnostics Market Overview
12.5.2 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis
12.5.3 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Product
12.5.4 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Test Type
12.5.5 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Application
12.5.6 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Infection Type
12.5.7 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By End Users
12.5.8 South and Central America Hospital Acquired Infections Diagnostics Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Hospital Acquired Infections Diagnostics Market
12.5.8.1.1 Brazil Hospital Acquired Infections Diagnostics Market by Product
12.5.8.1.2 Brazil Hospital Acquired Infections Diagnostics Market by Test Type
12.5.8.1.3 Brazil Hospital Acquired Infections Diagnostics Market by Application
12.5.8.1.4 Brazil Hospital Acquired Infections Diagnostics Market by Infection Type
12.5.8.1.5 Brazil Hospital Acquired Infections Diagnostics Market by End Users
12.5.8.2 Argentina Hospital Acquired Infections Diagnostics Market
12.5.8.2.1 Argentina Hospital Acquired Infections Diagnostics Market by Product
12.5.8.2.2 Argentina Hospital Acquired Infections Diagnostics Market by Test Type
12.5.8.2.3 Argentina Hospital Acquired Infections Diagnostics Market by Application
12.5.8.2.4 Argentina Hospital Acquired Infections Diagnostics Market by Infection Type
12.5.8.2.5 Argentina Hospital Acquired Infections Diagnostics Market by End Users
12.5.8.3 Rest of South and Central America Hospital Acquired Infections Diagnostics Market
12.5.8.3.1 Rest of South and Central America Hospital Acquired Infections Diagnostics Market by Product
12.5.8.3.2 Rest of South and Central America Hospital Acquired Infections Diagnostics Market by Test Type
12.5.8.3.3 Rest of South and Central America Hospital Acquired Infections Diagnostics Market by Application
12.5.8.3.4 Rest of South and Central America Hospital Acquired Infections Diagnostics Market by Infection Type
12.5.8.3.5 Rest of South and Central America Hospital Acquired Infections Diagnostics Market by End Users
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. HOSPITAL ACQUIRED INFECTIONS DIAGNOSTICS MARKET, KEY COMPANY PROFILES
14.1. ABBOTT LABORATORIES
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. ADVANDX
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. ALERE INC.
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. ASTRAZENECA PLC
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. BECTON DICKINSON AND COMPANY
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. HOLOGIC, INC
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. BAYER SCHERING PHARMA LLC
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. CEPHEID INC
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. ROCHE AG
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. DAIICHI SANKYO
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies
1. Abbott Laboratories
2. AdvanDX
3. Alere Inc.
4. AstraZeneca Plc
5. Becton Dickinson and Company
6. Hologic, Inc
7. Bayer Schering Pharma LLC
8. Cepheid Inc
9. Roche AG
10. Daiichi Sankyo
1. Abbott Laboratories
2. AdvanDX
3. Alere Inc.
4. AstraZeneca Plc
5. Becton Dickinson and Company
6. Hologic, Inc
7. Bayer Schering Pharma LLC
8. Cepheid Inc
9. Roche AG
10. Daiichi Sankyo
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For